1071000-98-0,MFCD18382097
Catalog No.:AA008SP2

1071000-98-0 | FKGK 11

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$100.00   $70.00
- +
5mg
≥98%
in stock  
$335.00   $234.00
- +
10mg
≥98%
in stock  
$558.00   $390.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008SP2
Chemical Name:
FKGK 11
CAS Number:
1071000-98-0
Molecular Formula:
C13H13F5O
Molecular Weight:
280.2337
MDL Number:
MFCD18382097
SMILES:
O=C(C(C(F)(F)F)(F)F)CCCCc1ccccc1
Properties
Computed Properties
 
Complexity:
292  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.5  

Literature

Title: Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limb.

Journal: American journal of physiology. Renal physiology 20120401

Title: Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Journal: The American journal of pathology 20110701

Title: Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Journal: Journal of medicinal chemistry 20100513

Title: Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.

Journal: Journal of medicinal chemistry 20081225

Title: Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury.

Journal: Brain : a journal of neurology 20081001

Title: Kokotos G, et al. Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem. 2010 May 13;53(9):3602-10.

Title: Yan Xu, et al. Abstract 3525: Targeting Group VIA phospholipase A2 using small molecules for ovarian cancer treatment. Cancer Res (2011) 71 (8_Supplement): 3525.

Title: López-Vales R, et al. Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain. 2008 Oct;131(Pt 10):2620-31.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1071000-98-0 Molecular Formula|1071000-98-0 MDL|1071000-98-0 SMILES|1071000-98-0 FKGK 11
Catalog No.: AA008SP2
1071000-98-0,MFCD18382097
1071000-98-0 | FKGK 11
Pack Size: 1mg
Purity: ≥98%
in stock
$100.00 $70.00
Pack Size: 5mg
Purity: ≥98%
in stock
$335.00 $234.00
Pack Size: 10mg
Purity: ≥98%
in stock
$558.00 $390.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008SP2
Chemical Name: FKGK 11
CAS Number: 1071000-98-0
Molecular Formula: C13H13F5O
Molecular Weight: 280.2337
MDL Number: MFCD18382097
SMILES: O=C(C(C(F)(F)F)(F)F)CCCCc1ccccc1
Properties
Complexity: 292  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.5  
Literature fold

Title: Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limb.

Journal: American journal of physiology. Renal physiology20120401

Title: Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Journal: The American journal of pathology20110701

Title: Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Journal: Journal of medicinal chemistry20100513

Title: Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.

Journal: Journal of medicinal chemistry20081225

Title: Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury.

Journal: Brain : a journal of neurology20081001

Title: Kokotos G, et al. Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem. 2010 May 13;53(9):3602-10.

Title: Yan Xu, et al. Abstract 3525: Targeting Group VIA phospholipase A2 using small molecules for ovarian cancer treatment. Cancer Res (2011) 71 (8_Supplement): 3525.

Title: López-Vales R, et al. Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain. 2008 Oct;131(Pt 10):2620-31.

Building Blocks More >
103606-71-9
103606-71-9
3-(3-Nitro-phenyl)-prop-2-yn-1-ol
AA008SSM | MFCD04039146
115184-30-0
115184-30-0
2-(L-XYLO-TETRAHYDROXYBUTYL)-4(R)-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
AA008T0M | MFCD08703975
1207456-01-6
1207456-01-6
Bmn-673
AA008TBR | MFCD22666357
1109276-89-2
1109276-89-2
Pf-04620110
AA008TG6 | MFCD19443642
1201913-82-7
1201913-82-7
Tofogliflozin hydrate
AA008TKH | MFCD27665464
1005266-30-7
1005266-30-7
2-([(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)methoxy]methyl)oxirane
AA008TQH | MFCD09040950
10397-68-9
10397-68-9
2-Chloro-n,n-dimethylpropanamide
AA008U00 | MFCD07345678
1086266-55-8
1086266-55-8
2,2-diMethylazetidine
AA008U88 | MFCD13188859
103226-10-4
103226-10-4
5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE SODIUM SALT
AA008UHC | MFCD16714828
107865-00-9
107865-00-9
4-(3-Aminophenyl)phenol
AA008UQF | MFCD04117374
Submit
© 2017 AA BLOCKS, INC. All rights reserved.